Redner, R L <br/><br/>
Chromatin remodeling and leukemia: new therapeutic paradigms.  [electronic resource] 

 -  Blood  Jul 1999 
 - 417-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Antineoplastic Agents--therapeutic use<br/>Cell Differentiation--drug effects<br/>Chromatin--metabolism<br/>Chromosomal Proteins, Non-Histone--physiology<br/>Core Binding Factor Alpha 2 Subunit<br/>DNA-Binding Proteins--genetics<br/>Enzyme Inhibitors--therapeutic use<br/>Gene Expression Regulation, Leukemic<br/>Histone Deacetylase Inhibitors<br/>Histone-Lysine N-Methyltransferase<br/>Histones--chemistry<br/>Humans<br/>Leukemia--genetics<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Models, Genetic<br/>Myeloid-Lymphoid Leukemia Protein<br/>Neoplasm Proteins--physiology<br/>Nucleic Acid Conformation<br/>Nucleosomes--ultrastructure<br/>Oncogene Proteins, Fusion--physiology<br/>Protein Processing, Post-Translational<br/>Proto-Oncogenes<br/>RUNX1 Translocation Partner 1 Protein<br/>Recombinant Fusion Proteins--physiology<br/>Static Electricity<br/>Transcription Factors--physiology<br/>Translocation, Genetic<br/>Tretinoin--pharmacology